Profiel
Michael A. Fleming is currently Director at Sona Nanotech, Inc. since 2026.
Former roles include Senior Vice President-Commercial & Tysabri Brand at Elan Corp.
Plc, Head-Hematology Marketing at Genentech, Inc., Vice President-Commercial Operations at Nuvelo, Inc., Vice President-HIV Oncology Vaccines Business Unit at GlaxoSmithKline, Inc., and Chief Strategy Officer at Coherus Oncology, Inc. from 2021 to 2022.
Education includes an MBA from Rotman School of Management and undergraduate studies at Victoria College (Canada).
Actieve functies van Michael Fleming
| Bedrijven | Functie | Begin |
|---|---|---|
| SONA NANOTECH INC. | Directeur/Bestuurslid | 11-06-2026 |
Eerdere bekende functies van Michael Fleming
| Bedrijven | Functie | Einde |
|---|---|---|
| COHERUS ONCOLOGY, INC. | Corporate Officer/Principal | 01-01-2022 |
GlaxoSmithKline, Inc.
GlaxoSmithKline, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical products | Corporate Officer/Principal | - |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Verkoop & Marketing | - |
Nuvelo, Inc.
Nuvelo, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutic drugs using genomic technologies | Corporate Officer/Principal | - |
Elan Corp. Plc
Elan Corp. Plc Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals and drug delivery systems | Corporate Officer/Principal | - |
Opleiding van Michael Fleming
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 8 |
|---|---|
Elan Corp. Plc
Elan Corp. Plc Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals and drug delivery systems | Health Technology |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Health Technology |
Nuvelo, Inc.
Nuvelo, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutic drugs using genomic technologies | Health Technology |
Rotman School of Management
Rotman School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
GlaxoSmithKline, Inc.
GlaxoSmithKline, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical products | Health Technology |
Coherus BioSciences, Inc.
Coherus BioSciences, Inc. Pharmaceuticals: MajorHealth Technology Operates as a commercial-stage biopharmaceutical company that engages in research, development and commercialization of immunotherapies to treat cancer | Health Technology |
Victoria College (Canada)
Victoria College (Canada) Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sona Nanotech, Inc.
Sona Nanotech, Inc. Chemicals: SpecialtyProcess Industries Develops and manufactures rod-shaped gold nanoparticles | Process Industries |
















